53 related articles for article (PubMed ID: 24551297)
21. [Importance of immunohistochemical studies in the diagnosis and the prognostic evaluation of cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Review].
García-Tamayo J; Molina J; Blasco-Olaetxea E
Invest Clin; 2009 Jun; 50(2):241-50. PubMed ID: 19662819
[TBL] [Abstract][Full Text] [Related]
22. Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.
Caffarel MM; Coleman N
J Pathol; 2014 Mar; 232(4):386-90. PubMed ID: 24659184
[TBL] [Abstract][Full Text] [Related]
23. EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix.
Li Q; Tang Y; Cheng X; Ji J; Zhang J; Zhou X
Int J Clin Exp Pathol; 2014; 7(2):733-41. PubMed ID: 24551297
[TBL] [Abstract][Full Text] [Related]
24. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.
Conesa-Zamora P; Torres-Moreno D; Isaac MA; Pérez-Guillermo M
Exp Mol Pathol; 2013 Oct; 95(2):151-5. PubMed ID: 23827764
[TBL] [Abstract][Full Text] [Related]
25. Gene amplification of EGFR and its clinical significance in various cervical (lesions) lesions using cytology and FISH.
Li Q; Cheng X; Ji J; Zhang J; Zhou X
Int J Clin Exp Pathol; 2014; 7(5):2477-83. PubMed ID: 24966959
[TBL] [Abstract][Full Text] [Related]
26. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
[TBL] [Abstract][Full Text] [Related]
27. HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
Regauer S; Reich O; Kashofer K
Am J Surg Pathol; 2022 Feb; 46(2):147-158. PubMed ID: 34387215
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
[TBL] [Abstract][Full Text] [Related]
29. New challenges and inspired answers for anticancer drug discovery and development.
Utsugi T
Jpn J Clin Oncol; 2013 Oct; 43(10):945-53. PubMed ID: 24014883
[TBL] [Abstract][Full Text] [Related]
30. pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members.
Zhang YJ; Gallis B; Taya M; Wang S; Ho RJ; Sasaki T
PLoS One; 2013; 8(3):e59086. PubMed ID: 23516601
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer.
Atmaca A; Werner D; Pauligk C; Steinmetz K; Wirtz R; Altmannsberger HM; Jäger E; Al-Batran SE
BMC Cancer; 2012 Nov; 12():524. PubMed ID: 23153332
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor as a biomarker for cervical cancer.
Soonthornthum T; Arias-Pulido H; Joste N; Lomo L; Muller C; Rutledge T; Verschraegen C
Ann Oncol; 2011 Oct; 22(10):2166-78. PubMed ID: 21325449
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.
Longatto-Filho A; Pinheiro C; Martinho O; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Baltazar F; Reis RM
BMC Cancer; 2009 Jun; 9():212. PubMed ID: 19563658
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for recurrent cervical cancer.
Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
Goncalves A; Fabbro M; Lhommé C; Gladieff L; Extra JM; Floquet A; Chaigneau L; Carrasco AT; Viens P
Gynecol Oncol; 2008 Jan; 108(1):42-6. PubMed ID: 17980406
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical analysis of epidermal growth factor receptors expression in malignant ovarian tumors].
Tomov S; Popovska S; Veselinova T; Gorchev G; Velkova A
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():42-7. PubMed ID: 16028404
[TBL] [Abstract][Full Text] [Related]
37. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.
Tangjitgamol S; Ramirez PT; Sun CC; See HT; Jhingran A; Kavanagh JJ; Deavers MT
Int J Gynecol Cancer; 2005; 15(4):646-56. PubMed ID: 16014119
[TBL] [Abstract][Full Text] [Related]
38. Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression.
Marzano R; Corrado G; Merola R; Sbiroli C; Guadagni F; Vizza E; Del Nonno F; Carosi M; Galati M M; Sperduti I; Cianciulli AM
Eur J Cancer; 2004 Jul; 40(10):1624-9. PubMed ID: 15196550
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
Hirsch FR; Varella-Garcia M; Bunn PA; Di Maria MV; Veve R; Bremmes RM; Barón AE; Zeng C; Franklin WA
J Clin Oncol; 2003 Oct; 21(20):3798-807. PubMed ID: 12953099
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
